Skip to content
10-Q

Quarterly Report

VOR BIOPHARMA INC. VOR

0000950170-25-107276

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 126.68M sh
Shares Diluted Q2 2025 · Jun 30, 2025 125.27M sh
Shares Diluted Q2 2025 · Jun 30, 2025 125.05M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.17M sh
Capex Q2 2025 · Jun 30, 2025 $383K
Capex Q2 2025 · Jun 30, 2024 $123K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$66.25M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$52.31M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $190.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $81.95M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $76.08M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$1.51B
Stockholders Equity Q2 2025 · Mar 31, 2025 $66.07M
Stockholders Equity Q2 2025 · Dec 31, 2024 $96.66M
Stockholders Equity Q2 2025 · Jun 30, 2024 $98.08M
Stockholders Equity Q2 2025 · Mar 31, 2024 $123.04M
Stockholders Equity Q2 2025 · Dec 31, 2023 $150.72M
Current Liabilities Q2 2025 · Jun 30, 2025 $58.77M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.61M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.71B
Total Liabilities Q2 2025 · Dec 31, 2024 $46.23M
Current Assets Q2 2025 · Jun 30, 2025 $204.93M
Current Assets Q2 2025 · Dec 31, 2024 $96.51M
Total Assets Q2 2025 · Jun 30, 2025 $205.37M
Total Assets Q2 2025 · Dec 31, 2024 $142.89M
Eps Diluted Q2 2025 · Jun 30, 2025 −$12.56
Eps Diluted Q2 2025 · Jun 30, 2025 −$12.84
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.41
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.86
Eps Basic Q2 2025 · Jun 30, 2025 −$12.56
Eps Basic Q2 2025 · Jun 30, 2025 −$12.84
Eps Basic Q2 2025 · Jun 30, 2024 −$0.41
Eps Basic Q2 2025 · Jun 30, 2024 −$0.86
Sga Expense Q2 2025 · Jun 30, 2025 $12.79M
Sga Expense Q2 2025 · Jun 30, 2025 $19.38M
Sga Expense Q2 2025 · Jun 30, 2024 $7.21M
Sga Expense Q2 2025 · Jun 30, 2024 $15.22M
Rd Expense Q2 2025 · Jun 30, 2025 $261.5M
Rd Expense Q2 2025 · Jun 30, 2025 $288.2M
Rd Expense Q2 2025 · Jun 30, 2024 $21.82M
Rd Expense Q2 2025 · Jun 30, 2024 $46.15M
Net Income Q2 2025 · Jun 30, 2025 −$1.57B
Net Income Q2 2025 · Jun 30, 2025 −$1.61B
Net Income Q2 2025 · Mar 31, 2025 −$32.49M
Net Income Q2 2025 · Jun 30, 2024 −$27.84M
Net Income Q2 2025 · Jun 30, 2024 −$58.64M
Net Income Q2 2025 · Mar 31, 2024 −$30.8M
Operating Income Q2 2025 · Jun 30, 2025 −$274.28M
Operating Income Q2 2025 · Jun 30, 2025 −$307.58M
Operating Income Q2 2025 · Jun 30, 2024 −$29.04M
Operating Income Q2 2025 · Jun 30, 2024 −$61.36M